Device Trial Radar · NCT05329246
Validation of PMcardio AI-assisted Clinical Assistant in Primary Care
Last checked: Nov 20, 2026Latest source record: Aug 2, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
836
Actual
Start
Nov 22, 2021
Primary completion
Jun 30, 2022
Study completion Jun 30, 2022
Sponsor
- Lead sponsor
- Powerful MedicalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Apr 14, 2022
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 55 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study aimed to analyze and investigate whether the use of the PMcardio clinical assistant leads to a more efficient patient management in primary care and more accessible specialised care compared to usual standards of care and to assess the reliability and safety of the PMcardio smartphone application in the primary care use environment. Additionally, to evaluate time savings and cost saving implications of increased availability of specialised care at the primary care level.
Conditions
- Cardiovascular Diseases
- Medical Device
- Primary Health Care
- Electrocardiogram
- Dyspnea
- Chest Pain
- Syncope
- Breath Shortness
- General Practitioner
Interventions
AI-assisted Clinical Assistant PMcardioDevice
PMcardio is an AI-powered clinical assistant in the form of a mobile application empowering non-cardiologist healthcare workers with advanced cardiovascular diagnostic capabilities, recommending patient-specific suggestions for referral and facilitating remote consultations with specialized cardiologists.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to first cardiovascular-related consultationTime frame: From randomization to enrollment period completion (up to 6 months)
3 more outcomes with a free account
Locations
56 sites in 1 country. Site status is shown where the registry gives one.
MUZMED s.r.o.
Bardejov, Slovakia
55 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.